Impact of Buccal Bone Thickness on Pathological Peri-implant Bone Loss: A 3-year Prospective Cohort Study

Periimplantitis Clinical Trial

Official title:

Impact of Buccal Bone Thickness on Pathological Peri-implant Bone Loss: A 3-year Prospective Cohort Study

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02939222
• Other study ID #: 18002909-2
• Status: Withdrawn
• Phase: N/A
• Start date: October 1, 2016
• Est. completion date: December 1, 2023

Study information

• Verified date: March 2020
• Source: Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Implant placement may trigger bone trauma, which might result in 3-dimensional bone changes. While the process of peri-implant disease is not well understood, implant position within the bony structure might play a role. However, there is no data available on this regard.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 1, 2023
• Est. primary completion date: December 1, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients between 18 and 80 years old

• Patients requiring oral rehabilitation through supported prosthesis

• Patients with partial edentulism

• No antibiotic in the last 2 months

• No smoking or smoking <10 cigarettes a day

Exclusion Criteria:

• Systemic diseases uncontrolled

• Implants that because prosthetic characteristics can not be registered probing depth or attachment level appropriately

• Smoking> 10 cigarettes a day

• Pregnant Patients

• Implants that can not be followed in CICOM

• Patients who do not return to regular maintenance therapy every 3-6meses

• Patients who are not controlled periodontal disease

Related Conditions & MeSH terms

• Oral Surgery
• Peri-Implantitis
• Periimplantitis

Intervention

Device:
• Implant placement
Routine implant placement in the ideal three dimensional implant position

Locations

Country	Name	City	State
Spain	Centro de Implantologia Cirugia Oral y Maxiofacial	Badajoz

Sponsors (1)

Lead Sponsor	Collaborator
Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Frequency of peri-implantitis	Control by routine x-ray peri-implant bone loss	3-years